How does (Can-C™ N-Acetylcarnosine) actually work to reverse cataracts?

It is now known that cataracts are the result of elevating levels of “ascorbate oxidation” or oxidative stress due in part to oxygen free radicals in the eyes of humans and animals. This unchecked oxidation results in the cross linking of lens proteins, which is a slow glycosylation process. Cross linking of the lens proteins eventually causes a yellowing or browning pigmentation of the lens or (lens opacification) limiting the amount of light that reaches the retina, resulting in worsening vision.


Introducing Nac-C Plus™ A Wise Choice for your Eyes Dr. Mark Babizhayev, a leading biophysicist in the area of natural peptides and their unique ability to reverse oxidation has developed and patented this specific oral formulation to effectively sustain the activity of Can-C eye drops for longer periods within the eye tissues. When taken consistently


[facts serving=”3 Capsules” container=”30″ ingredients=”Micro-crystalline Cellulose, Di Basic Calcium Phosphate, Magnesium Stearate, Aerosil, Vegetarian Capsule. ” info=” Note: Keep out of reach of children. Not for use by pregnant or lactating women.The above information is the translation of the manufacturer’s insert. It is provided under the supplying company’s terms and conditions and should not replace


A New Breakthrough from, Wise Choice Medicine Nac-C Plus tablets previously named Can-C Plus, are now available in US and European Markets: Patents: (WO 2004/028536 A1; WO 94/19325; WO 95/12581; WO 2004/064866 A1) Synergism of histidyl dipeptides and amino acids proven to be benefical in ophthalmic treatments. With the knowledge that there is a natural


New Hope for Macular Degeneration The study was monitored by world renowned endocrine specialist and melatonin expert Walter Pierpaoli MD, PhD. who was also responsible for the refinement of the bonded melatonin formulation used in the trial. DR. Walter Pierpaoli is director of the Jean Choay Institute for Biomedicals Research, Switzerland and President of the


Within 6 months 90% of the trial participants had improved their AMD condition. The improvements continued until the trial ended at 24 months. Clinical Publication Figure 1 – – Before and after fundus pics were taken of all trial participants. Complete Study Overview Figure 1: The left slide shows the eye of a 67 year


 New Breakthrough for Age-Related Macular Degeneration ARMeD™ Advanced Retinal Support formula is based on published research conducted by Changxian Yi et al, – titled “Effects of melatonin in age-related macular degeneration”, Ann NY Acad Sci, 1057:384-392,2005 with assistance from the world renowned endrocrin specialist Dr. Walter Pierpaoli.  The ARMeD™ formula contains a unique melatonin from


Q. Are Can-C™ Eye Drops Really safe for animals? A: Yes, N-Acetylcarnosine (Can-C™) eye drops have been researched in humans and in animals for over ten years and used for more than five years by thousands in Russia, China, Europe and the US without any side effects or complications. In fact the antioxidant properties of